Deep Learning-Based Prediction Model for Cardiac Resynchronization Therapy Responders Using Electrocardiogram Data.
Hitoshi Mori, Yuya Fujisaki, Syunta Higuchi, Masataka Narita, Daisuke Kawano, Kazuhisa Matsumoto, Wataru Sasaki, Tsukasa Naganuma, Naomichi Tanaka, Kazuhiko Kuinose, Haruka Yamazaki, Hiroki Yamazaki, Wataru Yoshino, Toshiki Takeda, Yoshifumi Ikeda
Abstract
Open AccessBACKGROUND: Cardiac resynchronization therapy (CRT) is an established treatment for advanced heart failure, but approximately 30% of patients fail to respond. This study aimed to develop and evaluate deep learning models using preimplantation electrocardiogram (ECG) data to predict CRT response. METHODS: We conducted a retrospective analysis of 285 patients who underwent CRT implantations and completed a 6-month follow-up. Responders were defined as those exhibiting ≥ 15% left ventricular end-systolic volume reduction. Three models were developed: ResNet-18 model trained on ECG images, self-supervised learning (SSL) enhanced ResNet-18 model, and LightGBM model trained on time-series ECG data. Model performance was evaluated using accuracy, positive predictive value (PPV), and negative predictive value (NPV), averaged across 10 random seeds. Model interpretability using Gradient-weighted Class Activation Mapping (Grad-CAM) was performed on 36 responder cases. RESULTS: The SSL + ResNet-18 model demonstrated the most stable performance (accuracy 78.5% ± 5.5%) and PPV of 81.3%. The ResNet-18 model achieved the highest PPV of 84.2% but had lower accuracy (74.1%) and larger variability. The LightGBM model exhibited the highest accuracy (79.4%) but the lowest PPV at 72.8%. Grad-CAM showed that precordial leads were highlighted in 13 cases (36.1%), limb leads in 16 (44.4%), and both regions in 7 (19.4%), indicating heterogeneity in the model's focus and potential diversity in the electrical features contributing to CRT response prediction. CONCLUSION: AI models using preimplantation ECG data, particularly those based on image inputs, can effectively predict CRT responders. This approach may enhance patient selection and support personalized therapy strategies in CRT management.